Everything You Need to Know About the CAPTURE Clinical Trial
Dec 05, 2021•6 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The CAPTURE clinical trial aims to improve survival rates for women and men with ER+ HER2- breast cancer. This study will investigate the effectiveness of treatment with targeted cancer therapy (alpelisib) and chemotherapy (fulvestrant), compared to a chemotherapy (capecitabine) alone in men and women with ER+ HER2- breast cancer with a PIKC3A mutation.We spoke with the CAPTURE study chair, Professor Sarah-Jane Dawson, about this important clinical trial.
For the best experience, listen in Metacast app for iOS or Android